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Abstract 
Purpose: We have evaluated thoracic conformation of patients in order to derive a numeric value predictive of an 
increased dose to left anterior descending coronary artery (LAD), critical structure for the development of late radio 
induced cardiac morbidity.
Methods: We have evaluated 91 patients (36–88 years) affected by breast cancer stage I–II (Tis–T1–2 N0–1), undergo-
ing adjuvant radiotherapy with conventional fractionation. For each patient on CT images was measured the distance 
between the back face of the sternum (manubrium) and the anterior face of body of the corresponding vertebra (a), 
and the distance measured on the line at 45° between the vertebral body of the same vertebra and the back face of 
the rib corresponding (b). The a/b ratio showed values between 0.626 and 1.123. We used the median value (0.821) 
as cut-off to divide the patients in two groups. We calculated in both groups: Volume (Vol) heart, Vol LAD with an 
expansion of 0.6 mm; Dmean LAD (Gy); Dmax LAD (Gy); V10–V20–V30 (%) LAD and we correlated these values with 
parametric and non-parametric tests.
Results: The Pearson test has showed a statistically significant correlation between Vol breast and V10, V20, V30 
with borderline significance (p = 0.006; p = 0.02; p = 0.05). The data were confirmed by testing non-parametric 
Kendall (tau = 0.004; tau = 0.015; tau = 0.016) and Spearman (rho = 0.003; rho = 0.016; rho = 0.015). We conducted 
categorizing into quartiles of breast volume and evaluated the correlation with a/b. We have found a significative 
correlation (p = 0.01) between small Vol breast (≤660.23 cc) and a/b < 0.0821 and greater Vol breast (>660.23 cc) with 
a/b > 0.0821. From the evaluation of the distribution of V10 in the two groups taking account of the Dmean ≤5 or >5 
significance was found with a/b; Chi square 0.009 (0.01). Values ≤5 were observed in women with a/b < 0.0821. Values 
>5 in women with a/b > 0.0821.
Conclusions: The geometric conformity of chest thorax considering a/b and the value of 0.0821 can reveals an 
important parameter in the selection of patients suitable for radiation therapy on left breast in order to evaluate the 
risk of late cardiac events. This consideration during treatment planning can change the technique or the set-up 
allowing the development of a customized plan.
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Background
In early-stage breast cancer, the conserving therapy 
and whole breast radiation treatment are an the stand-
ard option for both local control of the tumor and for 
esthetic results (Early Breast Cancer Trialists’ Collabo-
rative Group 2000; Gasparini et  al. 1991; Rose et  al. 
1989). An open question in the radiotherapy planning 
for early breast cancer is the potential toxicity on the 
heart even if cardiac damage is correlated to the heart-
absorbed dose and differs between left- and right-breast 
radiation therapy (Gagliardi et  al. 1996). Some factors, 
as age, hypertension, diabetes mellitus, total choles-
terol, family history of early myocardial infarction at 
age <60  years, smoking, may influence the individual 
patient’s risk of developing heart disease (Wilson et al. 
1998; Grundy et  al. 1999). Systemic therapies used for 
the treatment of early breast cancer such as anthracy-
clines, trastuzumab, taxanes, tamoxifen, and letrozole 
have increased over the last few decades and these may 
potentiate the radiation’s effects on the heart (Offersen 
et al. 2011).
The predominance of ischemic heart disease indi-
cates that the coronary arteries and in particular the 
left anterior descending artery (LAD) may be the 
critical structure for development of late radiation 
induced heart morbidity. The anterior portion of the 
heart and the LAD territory are the cardiac area more 
often enclosed within the tangential radiation fields 
used to treat left breast cancer (Schultz-Hector and 
Trott 2007). Different strategies to minimize dose to 
the heart are being developed, such as the use of res-
piratory gated radiotherapy, or alternative position-
ing of the patient in prone position (Vikstrom et  al. 
2011; Kirby et  al. 2011; Kirby et  al. 2010). Although 
new techniques, including intensity-modulated radio-
therapy (Hurkmans et  al. 2002) combined with free 
breathing gating (Korreman et  al. 2006) and helical 
tomotherapy (Hui et  al. 2004), may further reduce 
radiation-induced cardiac toxicities (Prosnitz et  al. 
2005), the most important factors in limiting cardiac 
radiation are associated with the techniques used and 
the expertise of the radiation oncologist. The dose 
distribution in the heart is not homogeneous and the 
highest doses are likely to be delivered to the anterior 
heart, including the LAD. The Danish Breast Can-
cer Cooperative Group (DBCG)introduced a national 
guideline recommending the doses to the heart has 
tobe as low as possible and preferably result in a maxi-
mum of 20  Gy can be given to the LAD (Offersen 
et al. 2010). The aim of the work was to identify, from 
the study of the different thoracic conformation of 
patients, a numeric value predictive of increased dose 
on anterior descending branch of LAD.
Methods
We have selected ninety consecutive Caucasian females 
(median age 57.9), treated with radiotherapy for early 
left breast cancer, pathologic stage I–II, from January to 
December 2012 (Table 1).
All patients underwent conservative surgery and adju-
vant radiotherapy on whole breast (with or without boost 
on tumor bed) and without indication for regional nodal 
irradiation ≤3 positive nodes).
For each patient a CT simulation (Siemens somatom) 
was realized in supine position. Target Volumes were 
delineated according to the International Commission 
of Radiation Units criteria (International Commission of 
Radiation Units and Measurements - ICRU 1993; Inter-
national Commission of Radiation Units and Measure-
ments - ICRU 1999).
The target breast volume (clinical target volume; CTV) 
was extended from the clinical image plus second rib 
insertion in cranial direction, to the loss of CT appar-
ent breast in caudal direction and skin in anterior direc-
tion. Pectoral muscles, chest-wall muscles and sternal-rib 
junction were excluded. Lateral and medial border were 
highly variable depending on breast size and the amount 
of ptosis in the supine position. The planning target vol-
ume (PTV) was generated from the CTV volume by add-
ing a 7  mm margin in all directions and excluding the 
skin.





Breast side Left 91 (100 %)
Pathological tumor stage Tis 4 (5 %)
T1 64 (70 %)
T2 22 (24 %)
T3 1 (1 %)
Pathological node stage N0 60 (66 %)
N1 31 (34 %)
Stadio 0 4 (5 %)
I 55 (60 %)
II 32 (35 %)
Surgery Conservative surgery + biopsy of 
sentinel node
60 (66 %)
Conservative surgery + axillary 
node dissection
31 (34 %)
Histology Ductal Infiltring Carcinoma 74 (81 %)
Lobular Infiltring Carcinoma 8 (9 %)
Mixed Carcinoma 5 (6 %)
In-Situ Ductal Carcinoma 4 (4 %)
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The LAD was contoured separately from the heart, 
using mediastinal CT windows. The LAD is difficult to 
visualize in a CT scan because its location is inferred 
from the course of the anterior-interventricular groove, 
conseguentely we added a 10-mm axial margin to the 
LAD to allow for delineation uncertainty and respiratory/
cardiac motion (i.e. LAD + 1 cm).
Whole breast irradiation 3D-conformal treatments 
provided two equally-weighted opposed tangential fields 
using beams of photons 6 mV. The dose distribution was 
calculated and optimized using Pinnacle® System.
All patients were treated with a standard fractionation 
of dose: 50  Gy (2  Gy/fraction) to whole breast, and, for 
stage T1–T2–T3–N0–N1, a sequential additional dose of 
10 Gy (2 Gy/fraction) directed to original tumor site. For 
each patient we calculated the Dose-Volume Histograms 
(DVHs) to the target and organs at risk focusing on heart 
and LAD. For each plan on the CT-images we measured 
the distance between the posterior surface of the sternum 
and the anterior surface of body of the corresponding 
vertebra (a), and the distance measured on the line at 45°, 
between the anterior surface of vertebral body and the 
back face of the corresponding rib (b) Figs. 1a–b and 2. 
We calculated the median values of a/b measured in all 
patients and we used the value obtained as the cut-off to 
divide the patients into two groups. In the two groups, we 
calculated: cardiac Volume (cc); LAD volume with expan-
sion of 0.6  mm to consider moving the LAD resulting 
from the heart beat and breathing movements PRV LAD 
(cc); Dmean LAD (Gy); Dmax LAD (Gy); V10 (%) LAD; 
V20 (%) LAD; V30 (%) LAD. We correlated these values 
with parametric and non-parametric test (Pearson–Ken-
dall and Spearman test).
Results
The a/b ratio showed values between 0.626 and 1.123. 
The median value was 0.821 and was used to divide the 
patients in two groups. Group I included 46 patients with 
a/b > 0.821 (0.822–1.123). Group II included 45 patients 
with a/b ≤ 0.821 (0.626–0.821). The first correlation that 
we have performed was between breast volume and V10–
V20–V30 (LAD) in order to evaluate whether the breast 
volume could affect the dose to the LAD with the angle of 
the beams needed to cover the target (Fig. 3a–d)
The data concerning the values of Vol breast and values 
of the ratio a/b are reported respectively in Table 2.
We found with the Pearson test a statistically signifi-
cant correlation between Vol breast and V10, V20 and 
V30 with borderline significance (p  =  0.006; p  =  0.02; 
p  =  0.05, respectively). The data were confirmed by 
non-parametric test, such as Kendall (tau  =  0.004; 
tau  =  0.015; tau  =  0.016) and Spearman (rho  =  0.003; 
rho  =  0.016; rho  =  0.015). We conducted categorizing 
into quartiles of breast volume evaluated the correlation 
with a/b (Table 3).
We found significance (p  =  0.01) between small Vol 
breast and a/b ≤ 0.0821; a greater Vol breast has a greater 
correlation with a/b > 0.0821.
Finally, we evaluated the distribution V10 in the two 
groups taking account of the Dmean ≤5 or >5 and we 
found significance with a/b. Chi square 0.009 (0.01) 
(Table  4). Therefore patients with a/b  ≤  0.0821 have 
significant correlation with Dmean ≤5. Patients with 
a/b > 0.0821 have significant correlation with Dmean >5.
Discussion
Cardiac disease has been observed in patients receiving 
radiation to left chest wall after a left-side mastectomy, 
or due to irradiation on internal mammary chain. In 
other hand, modern radiotherapy techniques deliver less 
radiation to the heart than those of 30 years ago even to 
patients with left-side tumors (Jemal et  al. 2011; Violet 
and Harmer 2004). The predominance of ischaemic heart 
disease in the anterior area indicates that the coronary 
arteries and in particular the LAD may be the critical 
structure for development of late radiation induced heart 
morbidity. In radiotherapy of breast cancer, the range of 
doses to the heart has changed due to the development 
of new techniques, beam energy, target doses, different 
volumes, and contouring modalities, nevertheless many 
studies report that the mean cardiac dose is greater for 
left- thus right-breast irradiation (Taylor et al. 2009; Roy-
choudhuri et  al. 2007; Harris et  al. 2006). However, our 
knowledge regarding the risk factors modulating the 
acute affects of cardiac radiation are not still sufficient, 
data regard are required (Darby et  al. 2010). It appears 
that the cumulative dose and its fractioning determine 
acute and chronic cardiac effects of radiation therapy. In 
the past, pericarditis used to be the most common side 
effect in patients receiving traditional radiotherapy for 
Hodgkin’s disease (Carver et  al. 2007). Dose restriction 
to 30  Gy with lower daily fraction, different weighting 
of radiation fields, and blocking of the subcarinal region 
have been reported to reduce the incidence of pericardi-
tis from 20 to 2.5 %. The radiation may cause two types of 
cardiovascular disease: micro-vascular and macro-vascu-
lar disease. The first one is characterized by a decrease in 
capillary density causing chronic ischaemic heart disease 
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Fig. 1 Examples of measurement of the distance a and b
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and focal myocardial degeneration, and second one by 
the faster development of age-related atherosclerosis in 
the coronary arteries (Schultz-Hector and Trott 2007). 
However, there are patients with unfavourable anat-
omy combined with a tumor bed near to the heart who 
receive a high dose to the heart. Furthermore the aggres-
siveness of the adjuvant therapy of early breast cancer 
has increased over the last decades, thus the individual 
patient is often treated with several systemic therapies 
which may potentiate the radiation effects to the heart.
Our study, conducted on 91 patients selected for early 
left breast cancer, has identified a numeric value predic-
tive of increased dose on anterior descending branch 
of LAD, from the different thoracic conformation of 
patients. The results have demonstrated that the geomet-
ric data a/b and its value >0.0821 could be factors to be 
taken into account in the enrollment of left breast cancer 
patients, especially for use of new fractionation schemes 
in the treatment of breast cancer stage I–II and could 
be indicative towards a prone set-up or a different tech-
nique for these patients with a series of controls cardiac 
close together. The analysis of the Early Breast Cancer 
Trialists’ Collaborative Group (Paszat et  al. 1998; Darby 
et al. 2005) on the cause specific mortality among 20,000 
women at 10–20  years after primary treatment clearly 
demonstrated the effectiveness of adjuvant radiotherapy 
for the reduction of local recurrence by about a factor of 
3. However, this benefit did not translate into any survival 
Fig. 2 Graphical representation of a and b
Fig. 3 a DVH of patient with a/b: 0.747 and V10 PRV(LAD):1.28 %; V20–30–40–50 PRV(LAD): 0; b DVH of patient with a/b: 0.634 and V10 
PRV(LAD):18 %; V20 PRV(LAD):9.3 %; V30 PRV(LAD): 4.8 %; V40 PRV(LAD): 2.9 %; V50 PRV(LAD): 0; c DVH of patient with a/b: 0.756 and V10 
PRV(LAD):33.2 %; V20 PRV(LAD):24.8 %; V30 PRV(LAD): 17.7 %; V40 PRV(LAD): 11.6 %; V50 PRV(LAD): 2.1; d DVH of patient with a/b: 0.954 and V10 
PRV(LAD):53.2 %; V20 PRV(LAD):47.2 %; V30 PRV(LAD): 42.9 %; V40 PRV(LAD): 36.4 %; V50 PRV(LAD): 8 %
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benefit because it was offset by a statistically significant 
increase (about 30 %) in the annual death rate from cardi-
ovascular deaths, which was ascribed to inadvertent irra-
diation of the coronary arteries, the carotid arteries, and 
other major arteries. Then there is convincing evidence 
that radiation doses lower than 10 % of the doses usually 
noted as tolerance doses for the irradiated heart in radio-
therapy are associated with a significant increase in car-
diovascular morbidity after latencies of 10 years.
The problem of clinical research into radiation-
induced cardiovascular risk is the extremely long latency 
to symptomatic disease. The early perfusion changes 
which can be precisely quantified and recorded anatomi-
cally with modern non-invasive imaging techniques may 
prove ideal for the way forward. These changes occur 
early enough to develop, for example criteria of treat-
ment plan optimization in the radiotherapy of breast 
cancer patients. A comprehensive clinical and transla-
tional research program should address a range of open 
questions, all of which may have an impact on the choice 
and delivery of post-operative radiotherapy techniques: 
left breast irradiation in patients with early breast cancer 
involves radiation-induced cardiovascular disease risk. 
Although modern radiotherapy techniques are likely to 
reduce the prevalence and severity of heart disease, her 
incidence is expected to increase in cancer survivors 
who have received old radiotherapy regimens. The ade-
quate strategy for screening of heart disease remains a 
source of debate in the radiation and medical oncology 
community (Lancellotti et al. 2013). Nieder et al. (2007), 
claim that IMRT techniques are able to reduce radiation 
dose to heart and coronary arteries. The identification 
of patients that for thoracic conformation have greater 
risk of higher dosage to cardiac structures could be an 
important factor for discriminating type of treatment, 
of fractionation and type of positioning in radiation 
therapy. Pili G. et  al. had identified a method to evalu-
ate probability of late cardiac mortality, in the maximal 
heart distance (the maximal distance from the posterior 
edge of tangent field to the heart contour). However, no 
clear association was found between the maximal heart 
distance and cardiovascular disease risk, but assert that 
it is important to modify the treatment technique to 
decrease the irradiate cardiac volumes and reduce the 
potential risk of late RT-associated cardiac complica-
tions. The authors conclude that the preventive assay of 
geometric parameterization of the thorax could permit 
clinicians to choose and propose the safest therapeutic 
strategy for the patients (Pili et  al. 2011; Cammarota 
et al. 2014). As in our work, we looked for a correlation 
between the distance of the posterior surface of the ster-
num and the anterior surface of body of the correspond-
ing vertebra, and the distance measured on the line at 
45°, between the anterior surface of vertebral body and 
the back face of the corresponding rib. We found, with 
a statistically analysis, a significant correlation between 
Vol breast and V10, V20 and V30 with borderline signifi-
cance (p = 0.006; p = 0.02; p = 0.05, respectively). We 
found, also, the significance (p  =  0.01) between small 
Vol breast and a/b ≤  0.0821; a greater Vol breast has a 
greater correlation with a/b > 0.0821.
The anatomical variability is reflected by the volume 
range of the organs at risk included in the treatment of 
breast. The prone position enabled lower mean doses to 
the heart and lung, as compared with the supine position. 
Although techniques such as partial breast irradiation 
seems to be the safest and least likely to have cardio-
vascular events in the future. It’ important the accurate 
Table 2 Volume breast—ratio a/b
Breast volume a/b
N° 91 N° 91
Media 709.67 cc Media 0.82533
Median 660.23 cc Median 0.82100
SD 342.51 SD 0.085489
Range 137.6–2095.7 cc Range 0.626–1.123
Table 3 Volume breast categorized into quartiles
a/b Total
≤0.0821 >0.0821
Vol breast IQ 17 (37 %) 6 (13.3 %) 23 (25.3 %)
IIQ 8 (17.4 %) 15 (33.3 %) 23 (25.3 %)
IIIQ 14 (30.4 %) 9 (20 %) 23 (25.3 %)
IVQ 7 (15.2 %) 15 (33.3 %) 22 (24.2 %)
Total (%) 46 (100 %) 45 (100 %) 91 (100 %)
Table 4 Chi square
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selection of the patient, based on the disease stage but 
also on the anatomy, intended not only on the breast vol-
ume, but also on the conformation of the chest.
We think our work can contribute to find new elements 
able to offer each patient the most appropriate custom-
ized treatment.
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